Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia

Nicoletta Sulli; B. Shashaj

Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia

Nicoletta Sulli, B. Shashaj

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article › peer-review

Abstract

Aim: To evaluate blood glucose and HbA_1c levels, insulin dosage, hypoglycemia rate and body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous subcutaneous insulin infusion (CSII) in children and youth with type 1 diabetes mellitus (DM). Methods: A 6-month trial of pump therapy was carried out in 40 patients with type 1 DM and one with cystic fibrosis (CF) induced DM (25 males), aged 4-25 years (mean 13.5 ± 4.2 [SD]; 4-8 years, n = 6; 8-10 years, n = 8; 10-12 years, n = 4; 12-15 years, n = 11; >15 years, n = 12). Results: HbA_1c was significantly reduced from 9.5 ± 1.7% to 8.6 ± 1.2% at 3 months (p

Original language	English
Pages (from-to)	393-399
Number of pages	7
Journal	Journal of Pediatric Endocrinology and Metabolism
Volume	16
Issue number	3
Publication status	Published - 2003

Keywords

CSII
Diabetic children
Insulin pump therapy
Intensified treatment
Type 1 diabetes mellitus

ASJC Scopus subject areas

Endocrinology
Pediatrics, Perinatology, and Child Health

Cite this

@article{3d1ca972f7644c3684a37a2d989facdf,

title = "Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia",

abstract = "Aim: To evaluate blood glucose and HbA1c levels, insulin dosage, hypoglycemia rate and body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous subcutaneous insulin infusion (CSII) in children and youth with type 1 diabetes mellitus (DM). Methods: A 6-month trial of pump therapy was carried out in 40 patients with type 1 DM and one with cystic fibrosis (CF) induced DM (25 males), aged 4-25 years (mean 13.5 ± 4.2 [SD]; 4-8 years, n = 6; 8-10 years, n = 8; 10-12 years, n = 4; 12-15 years, n = 11; >15 years, n = 12). Results: HbA1c was significantly reduced from 9.5 ± 1.7% to 8.6 ± 1.2% at 3 months (p ",

keywords = "CSII, Diabetic children, Insulin pump therapy, Intensified treatment, Type 1 diabetes mellitus",

author = "Nicoletta Sulli and B. Shashaj",

year = "2003",

language = "English",

volume = "16",

pages = "393--399",

journal = "Journal of Pediatric Endocrinology and Metabolism",

issn = "0334-018X",

publisher = "Walter de Gruyter GmbH & Co. KG",

number = "3",

}

TY - JOUR

T1 - Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus

T2 - Decreased HbA1c with low risk of hypoglycemia

AU - Sulli, Nicoletta

AU - Shashaj, B.

PY - 2003

Y1 - 2003

N2 - Aim: To evaluate blood glucose and HbA1c levels, insulin dosage, hypoglycemia rate and body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous subcutaneous insulin infusion (CSII) in children and youth with type 1 diabetes mellitus (DM). Methods: A 6-month trial of pump therapy was carried out in 40 patients with type 1 DM and one with cystic fibrosis (CF) induced DM (25 males), aged 4-25 years (mean 13.5 ± 4.2 [SD]; 4-8 years, n = 6; 8-10 years, n = 8; 10-12 years, n = 4; 12-15 years, n = 11; >15 years, n = 12). Results: HbA1c was significantly reduced from 9.5 ± 1.7% to 8.6 ± 1.2% at 3 months (p

AB - Aim: To evaluate blood glucose and HbA1c levels, insulin dosage, hypoglycemia rate and body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous subcutaneous insulin infusion (CSII) in children and youth with type 1 diabetes mellitus (DM). Methods: A 6-month trial of pump therapy was carried out in 40 patients with type 1 DM and one with cystic fibrosis (CF) induced DM (25 males), aged 4-25 years (mean 13.5 ± 4.2 [SD]; 4-8 years, n = 6; 8-10 years, n = 8; 10-12 years, n = 4; 12-15 years, n = 11; >15 years, n = 12). Results: HbA1c was significantly reduced from 9.5 ± 1.7% to 8.6 ± 1.2% at 3 months (p

KW - CSII

KW - Diabetic children

KW - Insulin pump therapy

KW - Intensified treatment

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0141995489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141995489&partnerID=8YFLogxK

M3 - Article

C2 - 12705364

AN - SCOPUS:0141995489

VL - 16

SP - 393

EP - 399

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - 3

ER -

Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: Decreased HbA1c with low risk of hypoglycemia

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this